Skip to main content
Top
Published in: Rheumatology International 6/2005

01-09-2005 | Original Article

A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis

Authors: Ayse Cefle, Sevıl Kamali, Mehmet Sayarlioglu, Murat Inanc, Lale Ocal, Orhan Aral, Meral Konice, Ahmet Gul

Published in: Rheumatology International | Issue 6/2005

Login to get access

Abstract

Objective

This study investigates the clinical and demographic characteristics of familial Mediterranean fever (FMF) patients with and without amyloidosis.

Patients and methods

The clinical data of 503 patients with FMF (females:males 250:253) were reviewed. Fifty of these patients had amyloidosis (f:m 23:27).

Results

The ages of attack onset in patients with and without amyloidosis were 7.8±6.2 and 11.1±8.5, respectively (P<0.05). The time between disease onset and diagnosis was longer in patients with amyloidosis than those without (187.6±99.4 months and 132.5±110.2 months, respectively, P<0.001). More patients in the amyloidosis group had positive family histories of FMF (68% vs 54%, P<0.05). The frequencies of chest pain (78% vs 51%, P<0.001), arthritis ( 80% vs 60%, P<0.01), and erysipelas-like erythema (44% vs 16%, P<0.001) were higher in the amyloidosis group.

Conclusion

In the amyloidosis group, FMF-related manifestations of chest pain, arthritis, and erysipelas-like erythema are more frequent. Our results also support that long periods between disease onset and diagnosis are associated with a high risk of developing amyloidosis.
Literature
1.
go back to reference Sohar E, Gafni J, Pras M, Heller J (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253CrossRefPubMed Sohar E, Gafni J, Pras M, Heller J (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253CrossRefPubMed
3.
go back to reference Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and the treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005PubMed Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and the treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005PubMed
4.
go back to reference Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934PubMed Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934PubMed
5.
go back to reference Pras M, Bronshpigel N, Zemer D, Gafni J (1982) Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 150:22–26PubMed Pras M, Bronshpigel N, Zemer D, Gafni J (1982) Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 150:22–26PubMed
6.
go back to reference Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612–627PubMed Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612–627PubMed
7.
go back to reference Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623CrossRefPubMed Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623CrossRefPubMed
8.
go back to reference Ozdogan H, Arisoy N, Kasapcopur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed Ozdogan H, Arisoy N, Kasapcopur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed
9.
go back to reference Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, Tastan H, Kocak H, Ozkaya N, Elhan AH (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 39:67–72 Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, Tastan H, Kocak H, Ozkaya N, Elhan AH (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 39:67–72
10.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–85PubMed Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–85PubMed
11.
go back to reference Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mondjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67:1136–1143PubMed Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mondjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67:1136–1143PubMed
12.
go back to reference Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A (2003) Male sex coupled with articular manifestations causes a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30:308–312PubMed Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A (2003) Male sex coupled with articular manifestations causes a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30:308–312PubMed
13.
go back to reference Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155CrossRefPubMed Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155CrossRefPubMed
14.
go back to reference Kastner DL (2001) Intermittent and periodic arthritic syndromes. In: Koopman WJ (ed) Arthritis and allied conditions. A textbook of rheumatology, 14th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1400–1437 Kastner DL (2001) Intermittent and periodic arthritic syndromes. In: Koopman WJ (ed) Arthritis and allied conditions. A textbook of rheumatology, 14th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1400–1437
15.
go back to reference Pras M, Kastner DL (2000) Familial Mediterranean fever. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London 5:23.1–23.4 Pras M, Kastner DL (2000) Familial Mediterranean fever. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London 5:23.1–23.4
16.
go back to reference Ozdemir AI, Cavit S (1969) Familial Mediterranean fever among the Turkish people. Am J Gastroenterol 51:311–316PubMed Ozdemir AI, Cavit S (1969) Familial Mediterranean fever among the Turkish people. Am J Gastroenterol 51:311–316PubMed
17.
go back to reference Ozer FL, Kaplaman E, Zileli S (1971) Familial Mediterranean fever in Turkey: a report of 20 cases. Am J Med 50:336–339CrossRefPubMed Ozer FL, Kaplaman E, Zileli S (1971) Familial Mediterranean fever in Turkey: a report of 20 cases. Am J Med 50:336–339CrossRefPubMed
18.
go back to reference Dilsen N, Koniçe M, Aral O, Öcal L (1990) Amyloidosis associated with familial Mediterranean fever. The first international symposium on recurrent hereditary polyserositis. Amman, Jordan. Abstract book, pp 33–34 Dilsen N, Koniçe M, Aral O, Öcal L (1990) Amyloidosis associated with familial Mediterranean fever. The first international symposium on recurrent hereditary polyserositis. Amman, Jordan. Abstract book, pp 33–34
19.
go back to reference Yazici H, Ozdogan H (1997) Familial Mediterranean fever in Turkey. In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 66–71 Yazici H, Ozdogan H (1997) Familial Mediterranean fever in Turkey. In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 66–71
20.
go back to reference Grateau G (2000) The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol 12:61–64CrossRefPubMed Grateau G (2000) The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol 12:61–64CrossRefPubMed
21.
go back to reference Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6:95–97CrossRefPubMed Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6:95–97CrossRefPubMed
22.
go back to reference Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S (1999) MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694 V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88–97CrossRefPubMed Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S (1999) MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694 V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88–97CrossRefPubMed
23.
go back to reference Shohat M, Magal N, Shohat T, Chen X, Mimouni A, Lotan R (1999) Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7:287–292CrossRefPubMed Shohat M, Magal N, Shohat T, Chen X, Mimouni A, Lotan R (1999) Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7:287–292CrossRefPubMed
24.
go back to reference Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R (1999) Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103:70 Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R (1999) Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103:70
25.
go back to reference Pras E, Langevitz P, Livneh A, Zemer D, Migdal A, Padeh S, Lubetzky A, Aksentijevich I, Centola M, Zaks N, Deng Z, Sood R, Kastner DL, Pras M (1997) Genotype-phenotype correlation in familial Mediterranean fever (a preliminary report). In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 260–264 Pras E, Langevitz P, Livneh A, Zemer D, Migdal A, Padeh S, Lubetzky A, Aksentijevich I, Centola M, Zaks N, Deng Z, Sood R, Kastner DL, Pras M (1997) Genotype-phenotype correlation in familial Mediterranean fever (a preliminary report). In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 260–264
26.
go back to reference Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1–6PubMed Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1–6PubMed
27.
go back to reference Kone Paut I, Dubue M, Sportouch J, Minodier P, Garnier JM, Touıtou I (2000) Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology 39:1275–1279 Kone Paut I, Dubue M, Sportouch J, Minodier P, Garnier JM, Touıtou I (2000) Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology 39:1275–1279
28.
go back to reference Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE (2000) Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 20:1703–1707 Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE (2000) Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 20:1703–1707
29.
go back to reference Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis. J Nephrol 16:431–434PubMed Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis. J Nephrol 16:431–434PubMed
Metadata
Title
A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis
Authors
Ayse Cefle
Sevıl Kamali
Mehmet Sayarlioglu
Murat Inanc
Lale Ocal
Orhan Aral
Meral Konice
Ahmet Gul
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0471-z

Other articles of this Issue 6/2005

Rheumatology International 6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.